Prices delayed by at least 15 minutes | Print
Valirx PLC (VAL)
ORD 0.1POpen
0.475p
Previous close
0.475p
Trade high
0.485p
Volume
385,000
Year high
4.4894p
Year low
0.375p
Dividend yield
–
Market capitalisation
£1.82 mn
P/E ratio
–
ISIN
GB00BLH13C52
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers,specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, VAL401 for lung cancer, VAL301, BC201, CLX001, and other drug candidates in their different stages of development.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 29/04/2025 | 03:12:23 | 0.485 | 67,000 | 324.95 |
| 29/04/2025 | 11:15:03 | 0.48 | 200,000 | 960.00 |
| 29/04/2025 | 10:25:56 | 0.45 | 100,000 | 450.00 |
| 29/04/2025 | 10:16:16 | 0.4555 | 17,000 | 77.44 |
| 29/04/2025 | 09:48:44 | 0.4555 | 1,000 | 4.56 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.